SK Chemicals

285130 · KOSPI

Public Market Listing

285130KOSPI

KOSPI primary exchange listing

Live quotes, historical charts, and market capitalization for SK Chemicals are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(1 total)
1Total Assets
0Approved
0Phase 3 / Filed
1Phase 1–2 / Early
1Diseases
Showing 1 of 1 assets
Target & Modality
Preclinical / Unstaged
PDE3 inhibitor (cilostazol) + herbal adjunct (Ginkgo biloba)Small molecule
Atherosclerotic Cardiovascular Disease

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

Annual history (2 years)

PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2025-FY$1.7B—$393M—report ↗
View 1 more year
PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2024-FY$1.3B——$33Mreport ↗